FDA appoints new commissioner’s chief of staff
SILVER SPRING, Md. — The Food and Drug Administration has appointed a new chief of staff for commissioner Margaret Hamburg, according to a letter sent to agency employees Monday.
In the letter, Hamburg announced the appointment of Lisa Barclay. Barclay, currently a partner at the Washington law firm Zuckerman Spaeder, will replace Molly Muldoon, who was previously chief of staff and more recently the agency’s acting COO.
Barclay previously worked with the FDA in the 1990s, with the Commissioner’s Office of Policy, and also has worked on Capitol Hill and as a law clerk for senior judge William Bryant of the U.S. District Court for the District of Columbia.
Abbott announces results of phase-3 trial of Humira
ABBOTT PARK, Ill. — A large number of patients with a serious form of arthritis experienced improvement in their condition after taking a drug made by Abbott Labs for three months, according to results of a late-stage clinical trial announced Monday.
Abbott announced results of the phase-3 "ABILITY-1" study of Humira (adalimumab) in patients with active nonradiographic axial spondyloarthritis, also known as AxSpA. AxSpA is a debilitating condition that causes inflammatory lower back pain and can be accompanied by such symptoms as arthritis and inflammation of the eye and gastrointestinal tract.
The primary goal of the trial was a 40% improvement in patients’ condition according to the Assessment of SpondyloArthritis international Society criteria, or ASAS. After 12 weeks, the number of patients taking Humira who reached this goal was twice that of patients taking placebo, the company said.
Pharmacy benefit manager PMSI extends partnership with Walgreens
TAMPA, Fla. — PMSI on Friday confirmed its continued relationship with Walgreens to serve payers and injured workers through Walgreens nationwide network.
In addition, Walgreens also will continue to serve as PMSI’s exclusive mail-order service pharmacy provider — this extends a 17-year network relationship.
“PMSI and Walgreens work collaboratively to create network penetration programs for our customers that proactively contain costs and manage appropriate care for the injured worker,” said Lori Daugherty, president of pharmacy for PMSI. “We can rely on Walgreens for its clinical excellence and superior customer service — exactly what a pharmacy benefit manager needs in a pharmacy partner.”